Amy Hood, Executive Vice President and Chief Financial Officer of Microsoft Corp, filed a Form 4 on September 15, 2026, disclosing the sale of 41,674 shares of Microsoft common stock on September 14, 2026, pursuant to a Rule 10b5-1 trading plan.
Amy Coleman, Executive Vice President and Chief Human Resources Officer of Microsoft Corp, filed a Form 4 on September 15, 2026, disclosing a disposition of common stock shares on that same date.
Alice L. Jolla, Chief Accounting Officer of Microsoft Corp, filed a Form 4 on September 15, 2026, reporting a disposition of common stock shares on that same date.
Sumant Sinha, Chief Executive Officer and Director of ReNew Energy Global plc (NASDAQ:RNW), filed a Form 4 on September 15, 2026, disclosing the vesting of performance stock options and Performance Based Units on September 12 and September 13, 2026.
Joanne Thomopoulos, Executive Vice President of Human Resources at SSR Mining Inc., filed a Form 4 on September 15, 2026, reporting the acquisition of dividend equivalent restricted share units and performance share units on September 11, 2026.
A Form 4 filed on September 15, 2026 reports that Venkatramani Srinivasan, Head of Product Tech & Cust Op at Blend Labs, Inc. (NYSE:BLND), sold 74,705 shares of Class A Common Stock on September 11, 2026 pursuant to a pre-established Rule 10b5-1 trading plan.
Fady Adel Edward Farid, Chief Strategy Officer of SSR Mining Inc. (NASDAQ:SSRM), filed a Form 4 on September 15, 2026, reporting acquisitions of common shares and performance share units on September 11, 2026, all at a price of $0.
William K. MacNevin, Executive Vice President of Operations and Sustainability at SSR Mining Inc., filed a Form 4 on September 15, 2026, reporting the acquisition of dividend equivalent securities on September 11, 2026.
A Form 4 filed on September 15, 2026 discloses that Tomer Weingarten, President and CEO of SentinelOne, Inc. (NYSE:S), sold 114,890 shares of Class A common stock and converted 57,941 shares of Class B common stock on September 11, 2026.
Robert I. Blum, President and CEO of Cytokinetics Inc (NASDAQ:CYTK), filed a Form 4 on September 15, 2026, disclosing a series of transactions in common stock dated September 14-15, 2026, including option exercises, open-market sales, charitable gifts, and trust transfers.